The Pharmacy Times® Women's Health Resource Center is a comprehensive resource for clinical news and expert insights on issues related to health conditions that affect women, including gynecological health and maternal health.
January 31st 2025
Although there were increases in prescriptions during the studies’ durations, the proportion of anxiety or pain medications on the same day of intrauterine device (IUD) insertion procedures were low.
Pharmacy Focus Podcast: Women in Pharmacy Wednesday- Episode 7
November 3rd 2021Women leadership roles and mentorship is extremely important in the pharmacy field, and this week's episode features Dr. Andrea Collaro, Walgreens Boots Alliance, Senior Director, Brand Management/Product Development, Owned Brands Health & Wellness, who goes into more specifics.
Listen
Webcast: Women’s Health and the Role of the Pharmacist
November 3rd 2021Expert panelists delve into topics related to women's health and women's health care during the COVID-19 pandemic, including pregnancy and COVID-19 vaccine considerations and best practices for guiding decisions on birth control.
Watch
Psychedelic Drug in Early Stages of Development Could Have Potential for Postpartum Depression
October 28th 2021Nathan Bryson, PhD, chief scientific officer of Field Trip Health, said the company's new psychedelic compound, FT-104, could have potential uses in the treatment of postpartum depression.
Watch
Women Pharmacists Day: The Evolution of Women’s Role in US Pharmacy Practice
October 12th 2021Although October has long been celebrated as National Pharmacy Month, it is only in recent years that female pharmacists have been celebrated for their contributions to the profession and patient care.
Read More
Pharmacy Focus Podcast: Women in Pharmacy Wednesday- Episode 6
October 6th 2021The Pharmacy Times® Pharmacy Focus podcast provides the latest industry news and information, thought-leader insights, clinical updates, patient counseling tools, and innovative solutions for the everyday practice and business of pharmacy.
Listen
FDA Approves Tisotumab Vedotin-tftv for Previously Treated Recurrent, Metastatic Cervical Cancer
September 21st 2021Trial results showed a 24% confirmed objective response rate with a median duration of response of 8.3 months among patients with cervical cancer who received tisotumab vedotin-tftv.
Read More
Study: Children of Mothers With Diabetes During Pregnancy Have Increased Risk of Eye Problems
September 10th 2021The research team analyzed the associations between maternal diabetes before or during pregnancy and the risk of high refractive error (RE), which are conditions in which there is a failure of the eye to properly focus images on the retina.
Read More
Eating More Plant Foods May Lower Heart Disease Risk in Young Adults, Older Women
September 2nd 2021Compared to women who followed the Portfolio Diet less frequently, those with the closest alignment were 11% less likely to develop any type of cardiovascular disease, 14% less likely to develop coronary heart disease, and 17% less likely to develop heart failure.
Read More
FDA Approves Pembrolizumab, Lenvatinib Combination Therapy for Advanced Endometrial Carcinoma
July 22nd 2021The FDA has approved pembrolizumab in combination with lenvatinib for the treatment of advanced endometrial carcinoma that is not microsatellite instability-high or mismatch repair deficient
Read More